From Pandemicity to Endemicity: The Journey of SARS-CoV-2

被引：0
|
作者：
Jaffar A. Al-Tawfiq
Dinh-Toi Chu
Van-Thuan Hoang
Ziad A. Memish
机构：
[1] Johns Hopkins Aramco Healthcare,Infectious Disease Unit, Specialty Internal Medicine
[2] Indiana University School of Medicine,Department of Medicine
[3] Johns Hopkins University School of Medicine,Department of Medicine
[4] Vietnam National University,Center for Biomedicine and Community Health, International School
[5] Thai Binh University of Medicine and Pharmacy,Director Research and Innovation Centre, King Saud Medical City, Ministry of Health and College of Medicine
[6] Alfaisal University,Hubert Department of Global Health, Rollins School of Public Health
[7] Emory University,undefined
来源：
Journal of Epidemiology and Global Health | 2022年 / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：147 / 149
页数：2
相关论文
共 50 条
  • [1] From Pandemicity to Endemicity: The Journey of SARS-CoV-2
    Al-Tawfiq, Jaffar A.
    Chu, Dinh-Toi
    Hoang, Van-Thuan
    Memish, Ziad A.
    JOURNAL OF EPIDEMIOLOGY AND GLOBAL HEALTH, 2022, 12 (02) : 147 - 149
  • [2] Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations
    Cohen, Lily E.
    Spiro, David J.
    Viboud, Cecile
    PLOS PATHOGENS, 2022, 18 (06)
  • [3] Nowcasting towards sustainable SARS-CoV-2 endemicity
    Leung, Gabriel M.
    LANCET, 2021, 398 (10313): : 1781 - 1783
  • [4] Morbidity of SARS-CoV-2 in the evolution to endemicity and in comparison with influenza
    Istvan Bartha
    Cyrus Maher
    Victor Lavrenko
    Yi-Pei Chen
    Qiqing Tao
    Julia di Iulio
    Keith Boundy
    Elizabeth Kinter
    Wendy Yeh
    Davide Corti
    Amalio Telenti
    Communications Medicine, 4 (1):
  • [5] SARS-CoV-2: public health measures for managing the transition to endemicity
    Byrne, Paula
    Harding-Edgar, Louisa
    Pollock, Allyson M.
    JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2022, 115 (05) : 165 - 168
  • [6] Malarial Antibodies and Endemicity: Does It Affect SARS-CoV-2 Severity and Outcomes?
    Sethi, Prayas
    Ghosh, Tamoghna
    Chowdhury, Souradeep
    Bir, Raunak
    Verma, Nishant
    Pandey, Shivam
    Subramanian, Arulselvi
    Meena, Ved
    Nischal, Neeraj
    Bhattacharjee, Sulagna
    Aravindan, Ajisha
    Anand, Rahul K.
    Goswami, Devalina
    Aggarwal, Richa
    Wig, Naveet
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [7] Author Correction: Morbidity of SARS-CoV-2 in the evolution to endemicity and in comparison with influenza
    Istvan Bartha
    Cyrus Maher
    Victor Lavrenko
    Yi-Pei Chen
    Qiqing Tao
    Julia di Iulio
    Keith Boundy
    Elizabeth Kinter
    Wendy Yeh
    Davide Corti
    Amalio Telenti
    Communications Medicine, 5 (1):
  • [8] Endemicity Is Not a Victory: The Unmitigated Downside Risks of Widespread SARS-CoV-2 Transmission
    Stoddard, Madison
    Novokhodko, Alexander
    Sarkar, Sharanya
    Van Egeren, Debra
    White, Laura F.
    Hochberg, Natasha S.
    Rogers, Michael S.
    Zetter, Bruce
    Joseph-McCarthy, Diane
    Chakravarty, Arijit
    COVID, 2022, 2 (12): : 1689 - 1709
  • [9] Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore
    De Foo, Chuan
    Grepin, Karen A.
    Cook, Alex R.
    Hsu, Li Yang
    Bartos, Michael
    Singh, Sudhvir
    Asgari, Nima
    Teo, Yik Ying
    Heymann, David L.
    Legido-Quigley, Helena
    LANCET, 2021, 398 (10311): : 1547 - 1551
  • [10] Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
    Shahrajabian, Mohamad Hesam
    Sun, Wenli
    Cheng, Qi
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 62 - 83
12345